Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease.

Pereira JB, Janelidze S, Smith R, Mattsson-Carlgren N, Palmqvist S, Teunissen CE, Zetterberg H, Stomrud E, Ashton NJ, Blennow K, Hansson O.